|Systematic (IUPAC) name|
|AHFS/Drugs.com||International Drug Names|
|ATC code||G03AC02 (WHO) G03DC03 (WHO);
G03AA03 (WHO) G03AB02 (WHO) G03FA07 (WHO) G03FB02 (WHO) (combinations with estrogens)
|Molar mass||284.436 g/mol|
Lynestrenol (INN, USAN, BAN, JAN), also known as 17α-ethinyl-3-desoxy-19-nortestosterone or 17α-ethynyl-4-estren-17β-ol, is a steroidal progestin. It is a synthetic, orally active progestogen associated with numerous effects of the natural progesterone hormone. Lynestrenol has a strong progestational effect on the uterine endometrium (transforming proliferative endometrium into secretory one), inhibits secretion of gonadotropin, suppresses maturation of follicles in the ovaries and ovulation, reduces menstrual bleeding. This synthetic gestagen is associated with minimal estrogenic, androgenic and anabolic effects. Lynestrenol is used in treatment of hormonal disorders and diseases caused by insufficient secretion of the natural progesterone, except in case of risky pregnancies and prevention of miscarriage, since it is not efficient enough in this indication.
After oral administration lynestrenol is quickly resorbed and converted into pharmacologically active norethisterone, through which it demonstrates the main biological effects. The peak blood are reached within 2–4 hours after oral administration, 97% of the administered dose being bound to plasma proteins. Lynestrenol and its metabolites are predominantly excreted in the urine, less through feces, active metabolite norethisterone elimination halftime being 16-17 h.
In another approach to analogs, nortestosterone (1) is first converted to the dithioketal (2) by treatment with dithioglycol in the presence of boron trifluoride. (The mild conditions of this reaction compared to those usually employed in preparing the oxygen ketals probably accounts for the double bond remaining at 4,5). Treatment of this derivative with sodium in liquid ammonia affords the 3-desoxy analog (3). Oxidation by means of Jones reagent followed by ethynylation of the 17-ketone leads to the orally active progestin (6).
These are easily confused.
- Cingestol C5=C6 olefin
Lynestrenol was introduced in the early 1960s.
- M. S. de Winter, C. M. Siegmann and S. A. Szpilfogel, Chem. Ind. , 905 (1959).
- Consolidated List of Products Whose Consumption And/or Sale Have Been Banned, Withdrawn, Severely Restricted Or Not Approved by Governments. United Nations Publications. 1983. pp. 134–. ISBN 978-92-1-130230-1.
|This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.|
|This article about a steroid is a stub. You can help Wikipedia by expanding it.|